Sperm Mitochondria-Associated Cysteine-Rich Protein (SMCP), also known as mitochondrial capsule selenoprotein (MCS) or mitochondrial capsule protein (MCP), is a crucial protein localized in the mitochondrial capsule of sperm cells. This protein plays a significant role in the organization and stabilization of the helical structure of the sperm’s mitochondrial sheath .
SMCP is involved in enhancing sperm motility, which is essential for successful fertilization. The protein’s absence has been linked to male infertility due to reduced sperm motility and the inability to penetrate the oocyte zona pellucida . The protein is rapidly evolving and is rich in cysteine and proline, contributing to its structural properties .
The protein encoded by the SMCP gene localizes to the capsule associated with the mitochondrial outer membranes. It is thought to function in the organization and stabilization of the helical structure of the sperm’s mitochondrial sheath . This unique localization and structure differentiate sperm mitochondria from those of somatic cells, which are typically elongated, flattened, and arranged circumferentially to form a helical coiled sheath in the midpiece of the sperm flagellum .
SMCP has been identified as an autoantigen in various studies. Autoimmunity to sperm can be induced by immunization with isologous or autologous spermatozoa, resulting in autoimmune orchitis and aspermatogenesis of the testis . The protein is recognized by antibodies generated through isologous immunization with sperm, demonstrating its role as a sperm autoantigen .
Research on SMCP has provided insights into its role in sperm motility and fertility. The recombinant form of SMCP (human recombinant) is used in various studies to understand its biochemical characteristics and potential therapeutic applications. The protein’s role in enhancing sperm motility makes it a potential target for treating male infertility.